Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines

Oral Oncology

Volumn 48, Issue 8, 2012, Pages 678-685

  Tano, Tomoyuki ^a   Okamoto, Masato ^b,c   Kan, Shin ^d   Nakashiro, Koh Ichi ^a   Shimodaira, Shigetaka ^e   Yamashita, Naomi ^c   Kawakami, Yutaka ^b   Hamakawa, Hiroyuki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MUSASHINO UNIVERSITY   (Japan)

^d YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apoptosis; Head and neck cancer cells; OK 432; Toll like receptor 4

Indexed keywords

CASPASE 3; CASPASE 8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PICIBANIL; PROTEIN P53; TOLL LIKE RECEPTOR 4;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; GROWTH INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASES; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PICIBANIL; SALIVARY GLAND NEOPLASMS; TOLL-LIKE RECEPTOR 4;

EID: 84864416934     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.02.005     Document Type: Article

References (41)

1. H. Okamoto, S. Shoin, S. Koshimura, and R. Shimizu Studies on the anticancer and stretolysin S-forming abilities of hemolytic streptococci Jpn J Microbiol 11 1967 323 336
2. M. Torisu, M. Katano, Y. Kimura, H. Itoh, and M. Takesue New approach to management of malignant ascities with a streptococcus preparation, OK-432. Improvement of host immunity and prolongation of survival Surgery 93 1983 357 364 (Pubitemid 13086972)
3. Y. Watanebe, and T. Iwa Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer J Biol Response Mod 6 1987 169 180 (Pubitemid 17058392)
4. F. Kikkawa, M. Kawai, H. Oguchi, M. Kojima, H. Ishikawa, and M. Iwata Randomised study of immunotherapy with OK-432 in uterine cervical carcinoma Eur J Cancer 29A 1993 1542 1546 (Pubitemid 23251794)
5. Y. Maehara, T. Okuyama, Y. Kakeji, H. Baba, M. Fukusawa, and K. Sigimachi Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion Am J Surg 168 1994 36 40 (Pubitemid 24331015)
6. S. Kitahara, M. Ikeda, T. Inoue, T. Matsunaga, K. Yamaguchi, and E. Takayama Inhibition of head and neck metastatic and/or recurrent cancer by local administration of multi-cytokine inducer OK-432 J Laryngol Otol 110 1996 449 453
7. M. Sato, H. Yoshida, T. Yanagawa, Y. Yura, M. Urata, and M. Atsumi Effect of intradermal administration of streptococcal preparation OK-432 on interferon and natural killer cell activities in patients with oral cancer Int J Oral Surg 13 1984 7 15 (Pubitemid 14121546)
8. M. Sato, K. Harada, H. Yoshida, Y. Yura, M. Azuma, and H. Iga Therapy for oral squamous cell carcinoma by tegaful and streptococcal agent OK-432 in combination with radiotherapy: association of the therapeutic effect with differentiation and apoptosis in the cancer cells Apoptosis 2 1997 227 238 (Pubitemid 127505730)
9. K. Oshimi, S. Kano, F. Takaku, and K. Okumura Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432 J Natl Cancer Inst 65 1980 1265 1269 (Pubitemid 11196015)
10. M. Saito, T. Ebina, M. Koi, T. Yamaguchi, Y. Kameda, and N. Ishida Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes Cell Immunol 68 1982 187 192 (Pubitemid 12105301)
11. T. Misaki, Y. Watanebe, Y. Iida, A. Hidaka, K. Kasagi, and H. Fukushima Recruitment of T lymphocytes and induction of tumor necrosis factor in thyroid cancer by a local immunotherapy Cancer Immunol Immunother 35 1992 92 96
12. T. Fujimoto, R.B. Duda, A. Azilvasi, X. Chen, M. Mai, and M.A. O'Donnell Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state J Immunol 158 1997 5619 5626 (Pubitemid 127483964)
13. M. Okamoto, R. Kaji, H. Kasetani, H. Yoshida, M. Moriya, and M. Saito Purification and characterization of interferon-γ-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-γ-inducing activity of OK-432 J Immunother 13 1993 232 242 (Pubitemid 23163688)
14. H. Takada, Y. Kawabata, R. Arakaki, S. Kusumoto, K. Fukase, and Y. Suda Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities Infect Immun 63 1995 57 65
15. M. Okamoto, H. Gohda, G. Ohe, H. Yoshida, and M. Sato Cytokine-inducing activity and anti-tumor effect of liposome-incorporated interferon-γ- inducing molecule derived from OK-432, a streptococcal preparation J Immunother 23 2000 94 103 (Pubitemid 30079830)
16. M. Okamoto, G. Ohe, T. Oshikawa, H. Nishikawa, S. Furuichi, and H. Yoshida Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent Immunopharamacology 49 2000 363 376
17. M. Okamoto, G. Ohe, T. Oshikawa, S. Furuichi, H. Nishikawa, and T. Tano Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus Cancer Immunol Immunother 50 2001 408 416 (Pubitemid 33027985)
18. M. Okamoto, T. Oshikawa, G. Ohe, S. Furuichi, H. Nishikawa, and T. Tano Comparison of cytokine-inducing activity in a lipoteichoic acid-related molecule isolated from a penicillin-killed group A Streptococcus and untreated bacteria Int Immunopharmacol 1 2001 1957 1968 (Pubitemid 32835126)
19. M. Okamoto, G. Ohe, S. Furuichi, H. Nishikawa, T. Oshikawa, and T. Tano Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells Anticancer Res 22 2002 3229 3240
20. T. Oshikawa, M. Okamoto, G. Ohe, S. Furuichi, H. Nishikawa, and S.U. Ahmed Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-γ-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction Int Immunopharmacol 3 2003 643 655 (Pubitemid 36577292)
21. M. Okamoto, T. Oshikawa, G. Ohe, H. Nishikawa, S. Furuichi, and T. Tano Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice Int Immunopharmacol 1 2001 1789 1795 (Pubitemid 32772649)
22. M. Okamoto, T. Oshikawa, T. Tano, G. Ohe, S. Furuichi, and H. Nishikawa Involvement of Toll-like receptor 4 signaling in interferon-γ production and antitumor effect by streptococcal agent OK-432 J Natl Cancer Inst 95 2003 316 326 (Pubitemid 36336482)
23. F.L. Rock, G. Hardiman, J.C. Timans, R.A. Kastelein, and J.F. Bazen A family of human receptors structurally related to Drosophila Toll Proc Natl Acad Sci USA 95 1998 588 593 (Pubitemid 28083787)
24. A. Adrem, and R.J. Ulevitch Toll-like receptors in the induction of the innate immune response Nature 406 2000 782 787
25. R. Madhitov, P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, and S. Ghosh Myd88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways Mol Cell 2 1998 253 258 (Pubitemid 128373651)
26. M. Muzio, N. Polentarutti, D. Bosisio, P.P. Manoj Kumar, and A. Mantovani Toll-like receptor family and signaling pathway Biochem Soc Trans 28 2000 563 566
27. D. Iwaki, H. Mitsuzawa, S. Murakami, H. Sano, M. Konishi, and T. Akino The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus J Biol Chem 277 2002 24315 24320 (Pubitemid 34951951)
28. O. Takeuchi, A. Kaufmann, K. Grote, T. Kawai, K. Hoshino, and M. Morr Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway J Immunol 16 2000 554 557 (Pubitemid 30043671)
29. J.C. Chow, D.W. Young, D.T. Golenbock, W.J. Christ, and F. Gusovsky Toll-like receptor 4 mediates lipopolysaccharide-induced signal transduction J Biol Chem 274 1999 10689 10692
30. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, and H. Sanjo A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745 (Pubitemid 32015992)
31. R. Shimazu, S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, and K. Miyake MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 J Exp Med 189 1999 1777 1782 (Pubitemid 29272694)
32. A. Uehara, S. Sugawara, and H. Takada Priming of human oral epithelial cells by interferon-γ to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans J Med Microbiol 51 2002 626 634 (Pubitemid 34804286)
33. T. Obayashi, H. Tamura, S. Tanaka, M. Ohki, S. Takahashi, and M. Arai A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications Clin Chim Acta 149 1985 55 65 (Pubitemid 15054604)
34. M. Sato, H. Kawamata, K. Harada, K. Nakashiro, Y. Ikeda, and H. Gohda Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene Cancer Lett 112 1887 181 189
35. J.I. Chao, P.C. Kuo, and T.S. Hsu Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells J Biol Chem 279 2004 20267 20276
36. R. Haase, C.J. Kirschning, A. Sing, P. Schrottner, K. Fukase, and S. Kusumoto A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages J Immunol 171 2003 4294 4303 (Pubitemid 37238708)
37. S. Koshimura, R. Shimizu, A. Fujimura, and H. Okamoto Experimental anticancer studies. XXI. Effect of penicillin treatment of hemolytic Streptococcus on anticancer activity Gann 55 1964 233 236
38. B. Huang, J. Zhao, J.C. Unkeless, Z.H. Feng, and H. Xiong TLR signaling by tumor and immune cells: a double-edged sword Oncogene 27 2008 218 224
39. B. Petricevic, D. Vrbance, J. Jakic-Razumovic, L. Brcic, D. Rabic, and T. Badovinac Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer Med Oncol 2011 [Epub ahead of print]
40. C. Rydberg, A. Mansson, R. Uddman, K. Riesbeck, and L.O. Cardell Toll-like receptor agonists induce inflammation and cell death in a model head and neck squamous cell carcinoma Immunology 128 2009 e600 e611
41. N. Nomi, S. Kodama, and M. Suzuki Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway Oncol Rep 24 2010 225 231